An administrative tribunal erred when it let Medtronic Inc. escape from a pair of patent validity challenges, a Federal Circuit panel ruled Monday, ordering the Patent Trial and Appeal Board to reconsider a competitor’s arguments that the patents cover an obvious innovation.

Drugmakers AstraZeneca Pharmaceuticals LP and Bristol-Myers Squibb Co., and distributor McKesson Corp. urged a federal appeals court to affirm the dismissal of suits alleging that diabetes drugs caused heart failure in patients.

Novo Nordisk A/S’s weight-loss medications are under investigation by the European Union’s drugs regulator after a small number of reports of suicidal risks were referred to the watchdog.

Legislation to ban abortion in Iowa after six weeks will once again go before the state Legislature Tuesday, after a split decision by the state’s highest court blocked an earlier law from taking effect.

Wisconsin can partially proceed with a suit aimed at preventing county district attorneys from prosecuting doctors under an antiquated law that allegedly criminalized abortions.

Lawmakers return this week, aiming to make progress on key authorizations and appropriations ahead of August recess and looming deadlines this fall.